Back to device advisories
FDA device recallVulnerabilitiesPublished Oct 21, 2025

Beckman Coulter, Inc.: Radioimmunoassay, Cortisol

Updated under an hour ago ()

Beckman Coulter has confirmed a software anomaly on DxI 9000 Access Immunoassay Analyzer and the DxC 500i Clinical Analyzer that may prevent correct application of user-specified manual dilution factors when ordering additional tests for samples already "In Progress" using the same "Sample ID number". This can lead to false low or high patient results and potential delays in reporting, risking erroneous diagnoses if undetected.

Tags
FDA recall, medical device, class 2, Clinical Chemistry, Software design, Open, Classified
Related exam domains
CISSP 3: Security Architecture and Engineering; CISSP 8: Software Development Security
Source record id
Z-0215-2026
First seen by InfoSec Signals
Sep 23, 2026

Source: openFDA device recalls, U.S. Food and Drug Administration about this source more from it

Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.